Celldex Therapeutics, Inc. (CLDX) vs Disc Medicine, Inc. (IRON)
Celldex Therapeutics, Inc. and Disc Medicine, Inc. are both Biotechnology companies. Celldex Therapeutics, Inc. and Disc Medicine, Inc. are of similar size ($2.6B and $2.5B). Disc Medicine, Inc. has the higher net margin (0.00% vs −33,883.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Disc Medicine, Inc. leads on 9 and Celldex Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | CLDX | IRON | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 65.16% |
| Operating margin | (36,733.82%) | 0.00% | 0.00% |
| Net margin | (33,883.77%) | 0.00% | 0.00% |
| Free cash flow margin | (27,294.81%) | 0.00% | 0.00% |
| Return on equity | (43.88%) | (39.08%) | (57.72%) |
| Return on assets | (40.76%) | (35.12%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack